William Blair & Company
STML

William Blair & Company’s Stemline Therapeutics, Inc. STML Stock Holding History

William Blair & Company’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-9,022
Closed -$408K – 2043
2013
Q3 		$408K Buy
+9,022
New +$408K ﹤0.01% 1617